Reply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?'

Author

Llovet i Bayer, Josep Maria

Johnson, Philip J.

Publication date

2018-04-03T15:28:46Z

2018-04-03T15:28:46Z

2014-03-20

2018-04-03T15:28:46Z

Document Type

Article
Published version

Language

English

Subjects and keywords

Assaigs clínics de medicaments; Càncer de fetge; Drug testing; Liver cancer

Publisher

American Society of Clinical Oncology

Related items

Reproducció del document publicat a: https://doi.org/10.1200/JCO.2013.54.3033

Journal of Clinical Oncology, 2014, vol. 32, num. 9, p. 968-969

https://doi.org/10.1200/JCO.2013.54.3033

Rights

(c) American Society of Clinical Oncology, 2014